Updated Analysis of Complication Rates Associated With Invasive Diagnostic Procedures After Lung Cancer Screening-Reference-Cited by-同舟云学术

Updated Analysis of Complication Rates Associated With Invasive Diagnostic Procedures After Lung Cancer Screening

Published:2020-12-16 Issue:12 Volume:3 Page:e2029874
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Zhao Hui¹,Xu Ying¹,Huo Jinhai²³,Burks A. Cole⁴,Ost David E.⁵,Shih Ya-Chen Tina¹

Affiliation:

1. Section of Cancer Economics and Policy, Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston

2. Department of Health Services Research, Management and Policy, College of Public Health Professions, University of Florida, Gainesville

3. Now with WW HEOR-US Markets, Bristol Myers Squibb, Lawrenceville, New Jersey

4. Department of Pulmonary and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill

5. Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2774245/zhao_2020_ld_200185_1607525656.49084.pdf

Reference5 articles.

1. Reduced lung-cancer mortality with low-dose computed tomographic screening.;Aberle;N Engl J Med,2011

2. Complication rates and downstream medical costs associated with invasive diagnostic procedures for lung abnormalities in the community setting.;Huo;JAMA Intern Med,2019

3. Complication rates in a study of invasive diagnostic procedures for lung abnormalities.;Halliday;JAMA Intern Med,2019

4. Centers for Medicare and Medicaid Services. Medicare Coverage Database. National coverage determination (NCD) for lung cancer screening with low dose computed tomography (LDCT) (210.14). Accessed November 9, 2020. https://www.cms.gov/medicare-coverage-database/details/ncd-details.aspx?NCDId=364&ncdver=1&DocID=210.14&clickon=search&bc=gAAAAAgAAAAAAA%3d%3d&

5. Medicare Evidence Development and Coverage Advisory Committee. MEDCAC meeting 4/30/2014-lung cancer screening with low dose computed tomography. Accessed November 9, 2020. https://www.cms.gov/medicare-coverage-database/details/medcac-meeting-details.aspx?MEDCACId=68

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Commentary: It's all in the (cell-free) DNA: Risk stratification of high-risk pulmonary nodules;The Journal of Thoracic and Cardiovascular Surgery;2024-07

2. Improved five year mortality in an RCT of a lung cancer biomarker to select people for screening;2024-06-14

3. Impact of lung cancer screening on stage migration and mortality among the national Veterans Health Administration population with lung cancer;Cancer;2024-06-10

4. Radiomics and artificial intelligence for risk stratification of pulmonary nodules: Ready for primetime?;Cancer Biomarkers;2024-02-06

5. Lung cancer screening for never smokers: current evidence and future directions;Singapore Medical Journal;2024-01-16